曹桂华, 张毓鑫, 杨书宏, 陈万庚. 2001~2005年江苏省盐都区病毒性肝炎血清流行病学监测[J]. 疾病监测, 2006, 21(11): 577-581. DOI: 10.3784/j.issn.1003-9961.2006.11.577
引用本文: 曹桂华, 张毓鑫, 杨书宏, 陈万庚. 2001~2005年江苏省盐都区病毒性肝炎血清流行病学监测[J]. 疾病监测, 2006, 21(11): 577-581. DOI: 10.3784/j.issn.1003-9961.2006.11.577
CAO Gui-hua, ZHANG Yu-xin, YANG Shu-hong, CHEN Wan-geng. Seroepidemiological surveillance of viral hepatitis in Yandu District from 2001 to 2005.[J]. Disease Surveillance, 2006, 21(11): 577-581. DOI: 10.3784/j.issn.1003-9961.2006.11.577
Citation: CAO Gui-hua, ZHANG Yu-xin, YANG Shu-hong, CHEN Wan-geng. Seroepidemiological surveillance of viral hepatitis in Yandu District from 2001 to 2005.[J]. Disease Surveillance, 2006, 21(11): 577-581. DOI: 10.3784/j.issn.1003-9961.2006.11.577

2001~2005年江苏省盐都区病毒性肝炎血清流行病学监测

Seroepidemiological surveillance of viral hepatitis in Yandu District from 2001 to 2005.

  • 摘要: 目的研究一般人群血清病毒性肝炎免疫水平。方法在省级病毒性肝炎血清流行病学监测点内分别于2001、2003、2005年对一般人群免疫水平进行血清流行病学监测,用酶联免疫吸附法(ELISA)检测抗-HAV-IgG、HBsAg、抗-HBs、抗-HBc、抗-HCV等。结果抗-HAV-IgG总阳性检出率为82.38%,HBsAg总阳性检出率2.79%,抗-HBs总阳性检出率57.04%,抗-HBc总阳性检出率46.94%,抗-HCV总阳性检出率0.08%。结论一般人群甲型肝炎抗体较高,表明有关控制甲型肝炎的干预措施切实有效。乙型肝炎防治措施的重点应为,加强对10 ̄20岁年龄组的疫苗接种。

     

    Abstract: Objective The present study was conducted to get the knowledge of the serum im-mune level of general population against viral hepatitis.Methods Seroepidemiological surveillance was conducted on immune level of general population at provincial seroepidemiological surveillance spots for viral hepatitis in 2001,2003,2005 respectively.ELISA was adopted to detect HAV-IgG antibody,HBs antigen,HBs antibody,HBc antibody,HCV antibody and SO on.Results The to-tal positive detection rates of HAV-IgG antibody,HBs antigen,HBs antibody,HBc antibody and HCV antibody were respectively 82.38%,2.79%,57.04%,46.94%and 0.08%.Conclusion In general population,the level of Type A Hepatitis antibody was relatively high,which showed that the intervention measures to control Type A Hepatitis was quite effective.And the key point of the prevention and control of Type B Hepatitis should be tO strengthen vaccination in the group aged 10-20.

     

/

返回文章
返回